| Overview |
| bsm-90037r-50µL |
| Keratin 7 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Cytokeratin 7 |
| 12-48/469 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 3855 |
| P08729 |
| KRT7; Keratin 7; CK-7; SCL; K7; Keratin Type II Cytoskeletal 7; Sarcolectin 2; K2C7 2; CK7 2; Keratin 55K Type II; Cytoskeletal; Type-II Keratin Kb7; Keratin 7 Type II; Cytokeratin 7; Keratin Simple Epithelial Type I K7; Type II Mesothelial Keratin K7; Cytokeratin-7; Keratin-7 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |